
|Articles|September 1, 2009
Bladder augmentation: What the future holds
This article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.
Advertisement
Key Points
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











